A detailed history of O'Shaughnessy Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 78,009 shares of AMGN stock, worth $25.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
78,009
Previous 67,163 16.15%
Holding current value
$25.2 Million
Previous $19.1 Million 27.64%
% of portfolio
0.26%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $2.85 Million - $3.46 Million
10,846 Added 16.15%
78,009 $24.4 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $9.1 Million - $11 Million
-33,842 Reduced 33.51%
67,163 $19.1 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $10.1 Million - $11.4 Million
-39,443 Reduced 28.08%
101,005 $29.1 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $16 Million - $19.9 Million
-73,163 Reduced 34.25%
140,448 $37.7 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $12.5 Million - $14.8 Million
-58,288 Reduced 21.44%
213,611 $47.4 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $759,331 - $925,497
3,363 Added 1.25%
271,899 $65.7 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $7.25 Million - $9.21 Million
31,658 Added 13.36%
268,536 $70.5 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $3.61 Million - $4.07 Million
16,096 Added 7.29%
236,878 $53.4 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $843,475 - $938,641
3,656 Added 1.68%
220,782 $53.7 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $2.95 Million - $3.27 Million
13,476 Added 6.62%
217,126 $52.5 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $3.61 Million - $4.13 Million
18,157 Added 9.79%
203,650 $45.8 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $18 Million - $21.1 Million
85,018 Added 84.62%
185,493 $39.4 Million
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $15.8 Million - $17.5 Million
67,671 Added 206.29%
100,475 $24.5 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $1.42 Million - $1.65 Million
6,393 Added 24.21%
32,804 $8.16 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $34.8 Million - $41.5 Million
-160,963 Reduced 85.9%
26,411 $6.07 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $43.5 Million - $48.4 Million
-185,440 Reduced 49.74%
187,374 $47.7 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $15.6 Million - $19.1 Million
-78,680 Reduced 17.43%
372,814 $88 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $24.2 Million - $32.1 Million
-132,671 Reduced 22.71%
451,494 $91.6 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $4.67 Million - $6.01 Million
-24,698 Reduced 4.06%
584,165 $141 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $996,257 - $1.19 Million
-5,722 Reduced 0.93%
608,863 $118 Million
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $555,277 - $650,910
-3,331 Reduced 0.54%
614,585 $113 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $8.42 Million - $9.49 Million
46,561 Added 8.15%
617,916 $0
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $20.5 Million - $23.9 Million
114,855 Added 25.16%
571,355 $111 Million
Q3 2018

Nov 06, 2018

BUY
$185.29 - $208.89 $67.8 Million - $76.5 Million
366,027 Added 404.57%
456,500 $94.3 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $13.6 Million - $15.2 Million
81,623 Added 922.29%
90,473 $16.7 Million
Q1 2018

May 08, 2018

SELL
$169.43 - $198.0 $9,826 - $11,484
-58 Reduced 0.65%
8,850 $1.51 Million
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $41,353 - $46,204
-245 Reduced 2.68%
8,908 $1.55 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $1.09 Million - $1.24 Million
-6,495 Reduced 41.51%
9,153 $1.71 Million
Q2 2017

Aug 14, 2017

BUY
N/A
15,648
15,648 $2.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.